Donation

Image removed.
 
 
 
Multiple Myeloma:
Making Wise Treatment Choices
 
Image removed.

Remarkable progress has been made in the treatment of patients with multiple myeloma, and new drugs and therapies are on the horizon.

 
But, navigating the many treatments available and understanding the role and timing of transplant can be challenging.
 
Learn:
 
  • when patients with myeloma should consider having a stem cell transplant
  • maintenance therapy options for myeloma patients after transplant
  • the role of CAR T-cell therapy and other new therapies on the horizon to treat multiple myeloma 
 
at the workshop
 
Multiple Myeloma:
Stem Cell Transplant and Beyond
 
offered online at the
 
 
Participation is free but you must register first.
 
 
 
 
Meet the Speaker
Image removed.

 

Frits van Rhee, MD, PhD, MRCP, FRCPath  
 
Dr. Frits van Rhee is a Professor of Medicine and Clinical Director of the UAMS Myeloma Center at the University of Arkansas for Medical Sciences. He serves as the Director of the Myeloma Center Clinical Program in the Winthrop P. Rockefeller Cancer Institute, which is one of the largest practices for patients with multiple myeloma and related diseases in the world.  
 
Dr. van Rhee and his colleagues at UAMS pioneered many advances that have become standards of care, leading to improved survival rates for patients with myeloma. At the core of the successful outcomes is the total therapy approach which combines chemotherapy and autologous transplantation followed by a maintenance strategy.  
 
What Past Symposium Attendees Say
 
"These workshops allowed me to evaluate my current care level and guide me to future decisions. It feels so good to know information that my healthcare team has not mentioned and now I can have a useful conversation with them." Patrick
 
 
 
Book about Stem Cell Transplants Using Your Own Cells (autologous transplant)

 

 
Image removed.
 
A comprehensive, easy-to-read guide that discusses what you should know before, during and after a transplant using your own cells (autologous transplant).

Image removed.Image removed.

Image removed.
 
El libro guía al lector a través de lo que puede esperar antes, durante y después del trasplante e incluye la perspectiva de los pacientes y de los cuidadores también.

 

 
 
Meet our Growing List of
Symposium Partners
 
 
Kadmon
 
Jazz Pharmaceuticals
 
Omeros Corporation
 
Sobi
 
Syndax
 
William G. Pomeroy Foundation
 
City of Hope
 
Gamida Cell
 
Seagen
 
Colorado Blood Cancer Institute at Presbyterian St. Luke's Medical Center
 
Mayo Clinic in Arizona
 
Nebraska Medicine
 
Oregon Health & Sciences University
 
Huntsman Cancer Institute at University of Utah Health
 
Stanford Blood and Marrow Transplant and Cellular Therapy
 
The Leukemia & Lymphoma Society
 
Myeloma Center at the University of Arkansas for Medical Sciences
 
The University of Kansas Cancer Center, Blood and Marrow Transplant and Cellular Therapy Program
 
Lymphoma Research Foundation
 
Aplastic Anemia & MDS International Foundation
 
International Myeloma Foundation
 
To learn how you can join this prestigious list of partners email Lynne Spina at [email protected]
 
 
 
How Can BMT InfoNet Help You?
 
 
Visit our website at
 
or click on the links below for information that can help you through your transplant or CAR T-cell journey.
 
 
You can also phone us at
888-597-7674
847-433-3313
or
 
 
 
Image removed.
 
 
 
 
 
 
(847) 433-3313
 
Toll Free: (888) 597-7674
 
 
 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.